CDTX Cidara Therapeutics, Inc.: institutional ownership and insider trading
7 funds reported holding $491M of Cidara Therapeutics, Inc. in their latest 13F filings; in Q1 2026 funds net bought $0, with 0 new positions and 249 funds selling out; over the last 12 months insiders bought $0 and sold $2.19M on the open market.
Largest institutional holders of CDTX
- VANGUARD GROUP INC — $443M
- KRYGER CAPITAL Ltd — $40.9M
- AXA Investment Managers S.A. — $5.86M
- Bryce Point Capital, LLC — $381K
- CIBC WORLD MARKETS CORP — $286K
- COMERICA BANK — $2.56K
- CIBC Private Wealth Group LLC — $1.55K
Recent CDTX insider trades
- Dec 10, 2025: Ward Shane sold 9,959 shares ($2.19M)
- Sep 11, 2025: Davarpanah Nicole Negar sold 474 shares ($29.8K)
- Jun 26, 2025: RA Capital Healthcare Fund LP bought 2,272,727 shares ($100.0M)
- Jun 3, 2025: Mineo Chrysa bought 3,320 shares ($73.9K)
5%+ owners
- The Vanguard Group: 6.4% (Schedule 13G, filed Jan 30, 2026)